Chemoinformaics analysis of Tritriacontane-12,14-dione
| Molecular Weight | 492.873 | nRot | 30 |
| Heavy Atom Molecular Weight | 428.361 | nRig | 2 |
| Exact Molecular Weight | 492.491 | nRing | 0 |
| Solubility: LogS | -6.657 | nHRing | 0 |
| Solubility: LogP | 12.052 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 99 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 64 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 99.3888 |
| nHD | 0 | BPOL | 65.9412 |
| QED | 0.074 |
| Synth | 1.919 |
| Natural Product Likeliness | 0.397 |
| NR-PPAR-gamma | 0.966 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -5.398 |
| MDCK | 0.00000401 |
| BBB | 0.002 |
| PPB | 0.972517 |
| VDSS | 1.772 |
| FU | 0.00538582 |
| CYP1A2-inh | 0.033 |
| CYP1A2-sub | 0.14 |
| CYP2c19-inh | 0.108 |
| CYP2c19-sub | 0.04 |
| CYP2c9-inh | 0.03 |
| CYP2c9-sub | 0.986 |
| CYP2d6-inh | 0.032 |
| CYP2d6-sub | 0.011 |
| CYP3a4-inh | 0.196 |
| CYP3a4-sub | 0.014 |
| CL | 5.101 |
| T12 | 0.166 |
| hERG | 0.409 |
| Ames | 0.009 |
| ROA | 0.01 |
| SkinSen | 0.967 |
| Carcinogencity | 0.024 |
| EI | 0.916 |
| Respiratory | 0.977 |
| NR-Aromatase | 0.037 |
| Antiviral | No |
| Prediction | 0.542542 |